Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03715101Phase 1Completed
Phase 1, open-label, single-arm trial of rosuvastatin in hypercholesterolemia, sponsored by Seoul National University Hospital. Primary endpoints: Time to reach maximum plasma concentration at Day 21, Peak plasma concentration at Day 21 and 1 more. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03715101.